NO981594L - Treatment of infections caused by Helicobacter pylori - Google Patents

Treatment of infections caused by Helicobacter pylori

Info

Publication number
NO981594L
NO981594L NO981594A NO981594A NO981594L NO 981594 L NO981594 L NO 981594L NO 981594 A NO981594 A NO 981594A NO 981594 A NO981594 A NO 981594A NO 981594 L NO981594 L NO 981594L
Authority
NO
Norway
Prior art keywords
treatment
helicobacter pylori
infections caused
pylori
methods
Prior art date
Application number
NO981594A
Other languages
Norwegian (no)
Other versions
NO981594D0 (en
Inventor
Bow Ho
Original Assignee
Cortecs International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9520585.2A external-priority patent/GB9520585D0/en
Application filed by Cortecs International Ltd filed Critical Cortecs International Ltd
Publication of NO981594D0 publication Critical patent/NO981594D0/en
Publication of NO981594L publication Critical patent/NO981594L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nye fremgansmåter for behandling av H. pylori-infeksjoner, så vel som farmasøytiske preparater for anvendelse ved slike fremgangsmåter. Preparatene for konverteringen av spiralformen av H. pylori omfatter urease.New methods of treating H. pylori infections as well as pharmaceutical preparations for use in such methods. The preparations for the conversion of the helical form of H. pylori include urease.

NO981594A 1995-10-09 1998-04-07 Treatment of infections caused by Helicobacter pylori NO981594L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9520585.2A GB9520585D0 (en) 1995-10-09 1995-10-09 Therapeutic method
US1588296P 1996-04-19 1996-04-19
PCT/GB1996/002456 WO1997013527A1 (en) 1995-10-09 1996-10-08 Treatments of helicobacter pylori infections

Publications (2)

Publication Number Publication Date
NO981594D0 NO981594D0 (en) 1998-04-07
NO981594L true NO981594L (en) 1998-06-03

Family

ID=26307915

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981594A NO981594L (en) 1995-10-09 1998-04-07 Treatment of infections caused by Helicobacter pylori

Country Status (9)

Country Link
EP (1) EP0862458A1 (en)
JP (1) JPH11514998A (en)
KR (1) KR19990064104A (en)
CN (1) CN1201395A (en)
AU (1) AU7141096A (en)
BR (1) BR9611033A (en)
MX (1) MX9802809A (en)
NO (1) NO981594L (en)
WO (1) WO1997013527A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103667127A (en) * 2006-11-14 2014-03-26 根特大学 Culture of Helicobacter in vitro
US7939079B2 (en) 2006-11-14 2011-05-10 Universiteit Gent Helicobacter species and cultivation thereof
JP5145700B2 (en) * 2006-11-20 2013-02-20 学校法人慶應義塾 Career

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection

Also Published As

Publication number Publication date
MX9802809A (en) 1998-11-29
AU7141096A (en) 1997-04-30
EP0862458A1 (en) 1998-09-09
JPH11514998A (en) 1999-12-21
KR19990064104A (en) 1999-07-26
CN1201395A (en) 1998-12-09
WO1997013527A1 (en) 1997-04-17
NO981594D0 (en) 1998-04-07
BR9611033A (en) 1999-12-28

Similar Documents

Publication Publication Date Title
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
AU5799294A (en) Isoxazole-4-carboxamides and hydroxy-alkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
NO994256D0 (en) Small molecules useful in the treatment of inflammatory disease
TR199802676A2 (en) Method for the treatment and prevention of tumors, tumor-related diseases and cacaxia.
BR9610838A (en) Process for treating an individual having a pathological condition involving neovascularization.
MA26435A1 (en) AMIDO-SUBSTITUTED BENZYLAMINE DERIVATIVES, THEIR PRECURSOR DERIVATIVES FOR MEDICAMENTS, THEIR PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND TREATMENT METHOD USING THE SAME.
ES2189768T3 (en) REGIONAL ELEMENTARY SYNTHESIS OF RAPAMYCIN DERIVATIVES.
EA200101075A1 (en) NEW METHOD OF TREATMENT
NO980317L (en) Use of Calendula glycosides for the treatment of psoriasis
DE69729183D1 (en) DIHYDROBENZOFURANES AND RELATED COMPOUNDS USEFUL AS AN ANTI-FLAMMING AGENT
NO982874L (en) Pharmaceutical preparations with vitamin D analogues
GEP20032914B (en) Derivatives of 1,3,4-Oxadiazolone
CA2296560A1 (en) Amino acid derivatives useful to treat stroke
NO972449L (en) Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one-1,1-dioxide derivatives and preparations and process for use thereof
TR200402230T4 (en) O-substituted 6-methyl-tramadol derivatives
DE69613395D1 (en) SULFUR-CONTAINING DI-TER-BUTYLPHENOL COMPOUNDS USED AS AN ANTI-FLAMMING AGENT
CA2267165A1 (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis
NO981594L (en) Treatment of infections caused by Helicobacter pylori
MXPA05004121A (en) Methods of treating dry eye disease with lantibiotics.
DE69804766D1 (en) ISOFLAVON DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
NO975682L (en) Pyridiniminyl-1,2-benzisoxazoles and benzisothiazoles as anti-psychotic agents
NO970185L (en) Use of (S) -adenosyl-L-methionine (SAMe) and its physiologically compatible salts for the treatment of reperfusion injury triggered by temporal-focal ischemia
SE9602145D0 (en) New improved formulation for the treatment of thromboembolism
NO961429D0 (en) Process for the preparation of quinolone-containing oral preparations
NZ505085A (en) Pharmaceutical compositions comprising bipapcitide monocarboxylate and/or bipapcitide dicarboxylate for imaging and treating thrombi